Zepp Health Corporation (ZEPP)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Zepp Health Corporation (ZEPP) is down 83.2% since the beginning of the year. At $5 per share, ZEPP is trading 92.7% below its 52-week high of $62. Investors who bought $1,000 worth of ZEPP shares 5 years ago would now be looking at an investment worth $105.

Zepp Health Corporation (ZEPP) has returned -83.18% so far this year and -65.15% over the past 12 months.

Based on dividend-adjusted daily data since Feb 8, 2018, ZEPP's average daily return is +0.03%, while the average monthly return is +3.33%. At this rate, an investment would double in approximately 1.8 years.

Historically, 37% of months were positive and 63% were negative. The best month was Jul 2025 with a return of +406.0%, while the worst month was May 2026 at -53.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 9 months.

On a daily basis, ZEPP closed higher 45% of trading days. The best single day was Jul 11, 2025 with a return of +69.5%, while the worst single day was Jun 9, 2026 at -28.6%.

Zepp Health Corporation has an annualized alpha of -7.07%, beta of 0.99, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since February 08, 2018.

• This stock participated in 187.90% of S&P 500 Index downside but only 58.91% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ZEPP ranks 21 for risk / return — above 21% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.

Zepp Health Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Zepp Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Zepp Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zepp Health Corporation was 97.30%, occurring on Aug 5, 2024. The portfolio has not yet recovered.

The current Zepp Health Corporation drawdown is 94.06%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Zepp Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Zepp Health Corporation is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.